Keskinkılıç Bekir, Engin-Üstün Yaprak, Sanisoğlu Sema, Şahin Uygur Dilek, Keskin Hüseyin Levent, Karaahmetoğlu Selma, Özcan Ayşe, Esen Meral, Alkan Afra, Kabasakal Aysun, Şencan İrfan
Turkish Public Health Agency, Preliminary Investigation Committee for Maternal Deaths, Ministry of Health, Ankara, Turkey.
J Turk Ger Gynecol Assoc. 2017 Mar 15;18(1):20-25. doi: 10.4274/jtgga.2016.0244.
To analyze maternal deaths in Turkey due to hypertensive disorders.
In this retrospective study 812 maternal deaths were analyzed. Maternal demographic features, presence of antenatal care, medical and obstetric history, mode of delivery, and use emergency antihypertensive therapy were recorded. The delay model for each case was investigated.
Hypertensive disorders accounted for 15.5% (n=126) out of all maternal mortality. They were the third most frequent cause among all causes and the 2nd among direct causes of maternal deaths. Sixty-one (48.4%) cases were in severe preeclampsia or pre-existing hypertensive disorder with increased/superimposed proteinuria, 30.1% were in eclampsia, 9.5% cases were diagnosed as hemolysis, elevated liver enzymes, low platelet count syndrome, and 11.1% in pre-existing hypertension complicating pregnancy, childbirth, and puerperium without increased or superimposed proteinuria. The median age was 32 years, 37.3% women were ≥35 years. All deaths except for 2 cases occurred during the postpartum period. Twenty-three percent of deaths occurred in the first 48 hours postpartum, and 51.6% between 8-42 days. Intracranial hemorrhage was the major final cause of death with a rate of 41.3%. With the exception of fifteen patients with intracranial hemorrhage, emergency antihypertensive agents were not implemented in optimal dose and/or duration. A first and/or third delay was identified in 36.5% of cases.
Approximately one third of maternal death due to hypertensive disorders could be prevented. The importance of acute antihypertensive treatment should be emphasized because of most frequent cause of death was intracranial hemorrhage.
分析土耳其因高血压疾病导致的孕产妇死亡情况。
在这项回顾性研究中,分析了812例孕产妇死亡病例。记录了孕产妇的人口统计学特征、产前检查情况、内科和产科病史、分娩方式以及是否使用紧急降压治疗。对每个病例的延迟模型进行了研究。
高血压疾病占所有孕产妇死亡的15.5%(n = 126)。它们是所有死因中第三常见的原因,也是孕产妇直接死因中的第二常见原因。61例(48.4%)为重度子痫前期或既往有高血压疾病且蛋白尿增加/叠加,30.1%为子痫,9.5%的病例被诊断为溶血、肝酶升高、血小板减少综合征,11.1%为既往高血压合并妊娠、分娩和产褥期且无蛋白尿增加或叠加。中位年龄为32岁,37.3%的女性年龄≥35岁。除2例死亡外,所有死亡均发生在产后。23%的死亡发生在产后48小时内,51.6%发生在8 - 42天之间。颅内出血是主要的最终死因,发生率为41.3%。除15例颅内出血患者外,紧急降压药物未以最佳剂量和/或疗程使用。36.5%的病例存在一级和/或三级延迟。
因高血压疾病导致的孕产妇死亡中约三分之一是可以预防的。由于最常见的死因是颅内出血,应强调急性降压治疗的重要性。